Corbus Pharmaceuticals I...

NASDAQ: CRBP · Real-Time Price · USD
9.25
-0.38 (-3.95%)
At close: Aug 15, 2025, 3:59 PM
9.43
1.95%
Pre-market: Aug 18, 2025, 04:00 AM EDT

Corbus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-17.66M -16.98M -9.53M -13.78M -10M -6.9M -8.02M -10.05M -8.78M -17.74M -10.88M -8.78M -13.25M -9.44M -10.26M -2.18M -17.14M -16.07M
Depreciation & Amortization
-571K 81K 146K 102.31K 200K 151.69K 147.98K 152.81K 158.34K 181.87K 374.22K 374.8K 370.38K 368.45K 375.15K 418.6K 420.94K 424.55K
Stock-Based Compensation
1.56M 1.71M 1.63M 2.24M 1.29K 982.02K 799.18K 821.22K 823.38K 1.03M 1.27M 1.35M 1.51M 1.59M 1.79M 2.6M 2.51M 2.58M
Other Working Capital
316K -316K -4.23M -3.98M 1.38M -355.71K 2.49M -1.36M -333.33K 2.27M 982.75K 615.64K -672.59K -4.69M -1.56M -1.31M -1.71M -5.16M
Other Non-Cash Items
-929K -238K -628K -476K 1.66M 1.7M 2.67M 203.64K 229.24K -2.14K -182.63K 11.14K 801.12K 988.86K 429.12K 177.4K 173.81K 170.28K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -2.59M -131.58K -78.27K n/a n/a n/a n/a n/a 282.9K 906.48K -42.97K -63.42K
Change in Working Capital
1M -1M -2.55M -2.03M 488.89K -1.49M 988.88K 1.83M -149.11K 1.42M 1.96M -194.79K -1.66M -4.13M -2.32M -1.07M -3.45M -8.86M
Operating Cash Flow
-16.6M -16.42M -10.94M -13.94M -8.94M -7.97M -6.01M -7.18M -7.8M -15.11M -7.45M -7.25M -12.23M -10.62M -9.7M 856.95K -17.53M -21.81M
Capital Expenditures
n/a n/a n/a n/a 2.00 n/a n/a n/a n/a n/a -13.42M -13.44K -8.1K -13.45K -54.17K n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 0.45 0.55 8.1K n/a 7.04M 1.3K 3.8K 2.6K
Purchase of Investments
-17.62M -37.6M -11.24M -38.84M -24.83M -105.9M -3.33M -6.63M -10.62M -13.31M 2.4M -22.37M -59.9M -6.47M -10M -6.74M -13.1M -57.43M
Sales Maturities Of Investments
35.37M 55.73M 19.97M 23.47M 8.39M 7.66M 13.72M 17.52M 19.43M 18.86M 9.38M 16.4M 41.19M 49.45M 6.86M 7.02M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a -16.44K -98.24K 10.39K 10.9K 8.81K n/a 13.42M 13.44K 8.1K 42.98K -7.03M 7.02M 3.8K 2.6K
Investing Cash Flow
17.74M 18.12M 8.73M -15.37M -16.44M -98.24M 10.39M 10.9M 8.81M 5.55M 11.78M -5.97M -18.7M 42.96M -3.18M 284.1K -13.1M -57.42M
Debt Repayment
n/a n/a n/a -10.9M -2.27M -2.32M -1.83M -740.7K -152.1K -150.07K 234.32K -110.7K -330.11K -327.13K 767.94K -102.69K -305.58K -301.88K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a 6.69M -6.69M -73.84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.82M
Financial Cash Flow
n/a n/a -13K 25.04M 34.96M 106.58M -1.9M -820.5K 17.69K -113.01K 234.32K -110.7K -330.11K -327.13K 767.94K -102.69K -255.59K 60.41M
Net Cash Flow
1.14M 1.7M -2.23M -4.26M 9.58M 471.91K 2.47M 2.9M 1.02M -9.68M 4.56M -13.33M -31.26M 32.02M -12.11M 1.04M -30.88M -18.82M
Free Cash Flow
-16.6M -16.42M -10.94M -13.94M -8.94M -7.97M -6.01M -7.18M -7.8M -15.11M -20.88M -7.26M -12.24M -10.63M -9.76M 856.95K -17.53M -21.81M